Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation

Nature Medicine

Volumn 17, Issue 11, 2011, Pages 1490-1497

  Badeanlou, Leylla ^a   Furlan Freguia, Christian ^b   Yang, Guang ^a   Ruf, Wolfram ^b   Samad, Fahumiya ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN; TISSUE FACTOR VIIA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENETICS; HEMATOPOIETIC CELL; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BONE MARROW TRANSPLANTATION; DIET, HIGH-FAT; FACTOR VIIA; GLUCOSE; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TRANSPLANTATION CHIMERA;

MUS;

EID: 81255127280     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2461     Document Type: Article

References (60)

1. Kadowaki, T. et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792 (2006). (Pubitemid 44033298)
2. Oh, D.Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698 (2010).
3. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920 (2009).
4. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 (2009).
5. Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457 (2010).
6. Odegaard, J.I. et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120 (2007). (Pubitemid 47014427)
7. Rajagopal, S., Rajagopal, K. & Lefkowitz, R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373-386 (2010).
8. Wang, P. & DeFea, K.A. Protease-activated receptor-2 simultaneously directs β-arrestin-1-dependent inhibition and Gαq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry 45, 9374-9385 (2006). (Pubitemid 44223242)
9. Luan, B. et al. Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance. Nature 457, 1146-1149 (2009).
10. Wang, P., Kumar, P., Wang, C. & DeFea, K.A. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 α and β by protease-activated receptor 2 and β-arrestins. Biochem. J. 408, 221-230 (2007). (Pubitemid 350206345)
11. Zoudilova, M. et al. β-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J. Biol. Chem. 282, 20634-20646 (2007). (Pubitemid 47100047)
12. Wang, P., Jiang, Y., Wang, Y., Shyy, J.Y. & DeFea, K.A. β-arrestin inhibits CAMKKβ-dependent AMPK activation downstream of protease-activated-receptor-2. BMC Biochem. 11, 36 (2010).
13. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006). (Pubitemid 46024993)
14. De Taeye, B., Smith, L.H. & Vaughan, D.E. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol. 5, 149-154 (2005). (Pubitemid 40378745)
15. Gerrits, A.J., Koekman, C.A., Haeften, V.A.N.T.W. & Akkerman, J.W. Increased tissue factor expression in diabetes mellitus type 2 monocytes caused by insulin resistance. J. Thromb. Haemost. 9, 873-875 (2011).
16. Diamant, M. et al. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106, 2442-2447 (2002). (Pubitemid 35278799)
17. Kopp, C.W. et al. Weight loss reduces tissue factor in morbidly obese patients. Obes. Res. 11, 950-956 (2003). (Pubitemid 41137506)
18. Samad, F., Pandey, M. & Loskutoff, D.J. Tissue factor gene expression in the adipose tissues of obese mice. Proc. Natl. Acad. Sci. USA 95, 7591-7596 (1998). (Pubitemid 28293297)
19. Dorfleutner, A., Hintermann, E., Tarui, T., Takada, Y. & Ruf, W. Cross-talk of integrin α3β1 and tissue factor in cell migration. Mol. Biol. Cell 15, 4416-4425 (2004). (Pubitemid 39299092)
20. Schaffner, F. et al. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood 116, 6106-6113 (2010).
21. Redecha, P., Franzke, C.W., Ruf, W., Mackman, N. & Girardi, G. Neutrophil activation by the tissue factor/factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Invest. 118, 3453-3461 (2008).
22. Ahamed, J. et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl. Acad. Sci. USA 103, 13932-13937 (2006). (Pubitemid 44452960)
23. Versteeg, H.H. et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 111, 190-199 (2008).
24. Olefsky, J.M. & Glass, C.K. Macrophages, inflammation and insulin resistance. Annu. Rev. Physiol. 72, 219-246 (2010).
25. Patsouris, D. et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8, 301-309 (2008).
26. Cinti, S. et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355 (2005). (Pubitemid 41532523)
27. Guha, M. & Mackman, N. LPS induction of gene expression in human monocytes. Cell Signal. 13, 85-94 (2001). (Pubitemid 32222977)
28. Randolph, G.J., Luther, T., Albrecht, S., Magdolen, V. & Muller, W.A. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 92, 4167-4177 (1998). (Pubitemid 28544332)
29. Ahamed, J. et al. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood 109, 5251-5259 (2007). (Pubitemid 46890545)
30. Noorbakhsh, F. et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203, 425-435 (2006). (Pubitemid 43290851)
31. Odegaard, J.I. et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496-507 (2008). (Pubitemid 351729205)
32. Saberi, M. et al. Hematopoietic cell-specific deletion of Toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 10, 419-429 (2009).
33. Liu, L. et al. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J. Clin. Invest. 117, 1679-1689 (2007). (Pubitemid 46871352)
34. Pickersgill, L., Litherland, G.J., Greenberg, A.S., Walker, M. & Yeaman, S.J. Key role for ceramides in mediating insulin resistance in human muscle cells. J. Biol. Chem. 282, 12583-12589 (2007). (Pubitemid 47100630)
35. Snyder, L.A. et al. Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice. J. Thromb. Haemost. 6, 306-314 (2008).
36. Bradshaw, G. et al. Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 102, 11029-11034 (2005). (Pubitemid 41105987)
37. Mackman, N., Sawdey, M.S., Keeton, M.R. & Loskutoff, D.J. Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am. J. Pathol. 143, 76-84 (1993). (Pubitemid 24058162)
38. Samad, F., Pandey, M. & Loskutoff, D.J. Regulation of tissue factor gene expression in obesity. Blood 98, 3353-3358 (2001).
39. Venugopal, J., Hanashiro, K., Yang, Z.Z. & Nagamine, Y. Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes. Proc. Natl. Acad. Sci. USA 101, 17120-17125 (2004). (Pubitemid 39627784)
40. Kidani, T. et al. Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J. Atheroscler. Thromb. 17, 834-843 (2010).
41. Matsuzawa, Y. Adiponectin: a key player in obesity related disorders. Curr. Pharm. Des. 16, 1896-1901 (2010).
42. Qi, Y. et al. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524-529 (2004). (Pubitemid 38667912)
43. Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295 (2002). (Pubitemid 35373562)
44. Jäger, S., Handschin, C., St-Pierre, J. & Spiegelman, B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. USA 104, 12017-12022 (2007). (Pubitemid 47185622)
45. Lee, Y. et al. PPAR α is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc. Natl. Acad. Sci. USA 99, 11848-11853 (2002). (Pubitemid 34994487)
46. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. & Hotamisligil, G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614 (1997). (Pubitemid 27446179)
47. Guerre-Millo, M. et al. Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275, 16638-16642 (2000). (Pubitemid 30398891)
48. Surwit, R.S. et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc. Natl. Acad. Sci. USA 95, 4061-4065 (1998). (Pubitemid 28173254)
49. Fleury, C. et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 15, 269-272 (1997). (Pubitemid 27098720)
50. Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993). (Pubitemid 23036092)
51. Hotamisligil, G.S., Budavari, A., Murray, D. & Spiegelman, B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J. Clin. Invest. 94, 1543-1549 (1994).
52. Sabio, G. et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543 (2008).
53. Lumeng, C.N., Bodzin, J.L. & Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007). (Pubitemid 46048464)
54. Steinbrecher, K.A. et al. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin αMβ2 engagement of fibrinogen. Cancer Res. 70, 2634-2643 (2010).
55. Smiley, S.T., King, J.A. & Hancock, W.W. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167, 2887-2894 (2001). (Pubitemid 32768923)
56. Flick, M.J. et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo. J. Clin. Invest. 113, 1596-1606 (2004). (Pubitemid 39071683)
57. Melis, E. et al. Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. Biochem. Biophys. Res. Commun. 286, 580-586 (2001). (Pubitemid 32912986)
58. Damiano, B.P. et al. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288, 671-678 (1999). (Pubitemid 29119680)
59. Yang, G. et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 297, E211-E224 (2009).
60. Samad, F., Yamamoto, K. & Loskutoff, D.J. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-α and lipopolysaccharide. J. Clin. Invest. 97, 37-46 (1996).